A phase 1b/2 trial of lenvatinib plus pembrolizumab in patients with renal cell carcinoma

被引：0
|
作者：
Lee, C-H. [1 ]
Makker, V. [1 ]
Rasco, D. [2 ]
Taylor, M. [3 ]
Dutcus, C. [4 ]
Shumaker, R. [4 ]
Schmidt, E. V. [5 ]
Stepan, D. [4 ]
Li, D. [4 ]
Motzer, R. J. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Genitourinary Oncol, 1275 York Ave, New York, NY 10021 USA
[2] START, Med Oncol, San Antonio, TX USA
[3] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
[4] Eisai Inc, Woodcliff Lake, NJ USA
[5] Merck & Co Inc, Kenilworth, NJ USA
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
847O
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A phase 1b/2 trial of lenvatinib plus pembrolizumab in patients with squamous cell carcinoma of the head and neck
    Taylor, Matthew H.
    Rasco, Drew W.
    Brose, Marcia S.
    Vogelzang, Nicholas J.
    Richey, Stephen L.
    Cohen, Allen L.
    Richards, Donald A.
    Stepan, Daniel E.
    Dutcus, Corina E.
    Guo, Matthew
    Shumaker, Robert C.
    Schmidt, Emmett V.
    Young, Louise
    Wirth, Lori J.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 174 - 174
  • [2] A phase 1b trial of lenvatinib plus pembrolizumab in patients with unresectable hepatocellular carcinoma
    Ikeda, Masafumi
    Sung, Max W.
    Kudo, Masatoshi
    Kobayashi, Masahiro
    Baron, Ari D.
    Finn, Richard S.
    Kaneko, Shuichi
    Zhu, Andrew X.
    Kubota, Tomoki
    Kraljevic, Silvija
    Ishikawa, Kohei
    Siegel, Abby B.
    Kumada, Hiromitsu
    Young, Louise
    Okusaka, Takuji
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 105 - 105
  • [3] A Phase 1b trial of lenvatinib plus pembrolizumab in patients with unresectable hepatocellular carcinoma
    Ikeda, M.
    Sung, M. W.
    Kudo, M.
    Kobayashi, M.
    Baron, A. D.
    Finn, R. S.
    Kaneko, S.
    Zhu, A. X.
    Kubota, T.
    Kraljevic, S.
    Ishikawa, K.
    Siegel, A. B.
    Kumada, H.
    Okusaka, T.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 37 - 37
  • [4] A phase 1b/2 trial of lenvatinib plus pembrolizumab in patients with squamous cell carcinoma of the head and neck.
    Taylor, Matthew H.
    Rasco, Drew W.
    Brose, Marcia S.
    Vogelzang, Nicholas J.
    Richey, Stephen Lane
    Cohn, Allen Lee
    Richards, Donald A.
    Stepan, Daniel E.
    Dutcus, Corina E.
    Guo, Matthew
    Shumaker, Robert Charles
    Schmidt, Emmett V.
    Wirth, Lori J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] A Phase IB/II Trial of Lenvatinib plus Pembrolizumab in Patients With Renal Cell Carcinoma
    Lee, Chung-Han
    Makker, Vicky
    Rasco, Drew
    Taylor, Matthew
    Dutcus, Corina
    Shumaker, Robert
    Schmidt, Emmett
    Stepan, Daniel E.
    Li, Di
    Young, Louise
    Motzer, Robert
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 153 - 153
  • [6] A phase 1b study of lenvatinib plus pembrolizumab in unresectable hepatocellular carcinoma
    Finn, Richard
    Ikeda, Masafumi
    Zhu, Andrew
    Sung, Max W.
    Baron, Ari D.
    Kudo, Masatoshi
    Okusaka, Takuji
    Kobayashi, Masahiro
    Kumada, Hiromitsu
    Kaneko, Shuichi
    Pracht, Marc
    Mamontov, Konstantin
    Meyer, Tim
    Mody, Kalgi
    Kubota, Tomoki
    Dutcus, Corina E.
    Saito, Kenichi
    Siegel, Abby B.
    Dubrovsky, Leonid
    Llovet, Josep M.
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 : S120 - S121
  • [7] A phase 1b trial of lenvatinib (LEN) plus pembrolizumab (PEM) in patients (pts) with unresectable hepatocellular carcinoma (uHCC).
    Ikeda, Masafumi
    Sung, Max W.
    Kudo, Masatoshi
    Kobayashi, Masahiro
    Baron, Ari David
    Finn, Richard S.
    Kaneko, Shuichi
    Zhu, Andrew X.
    Kubota, Tomoki
    Kraljevic, Silvija
    Ishikawa, Kohei
    Siegel, Abby B.
    Kumada, Hiromitsu
    Okusaka, Takuji
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Lenvatinib (LEN) plus pembrolizumab (PEMBRO) treatment in patients (pts) with metastatic clear cell renal cell carcinoma (RCC): Final results of a phase 1b/2 trial.
    Lee, Chung-Han
    Shah, Amishi Yogesh
    Hsieh, James J.
    Rao, Arpit
    Pinto, Alvaro
    Bilen, Mehmet Asim
    Cohn, Allen Lee
    DiSimone, Christopher
    Shaffer, David R.
    Sarrio, Regina Girones
    Ribe, Sara Gunnestad
    Wu, Jane
    Schmidt, Emmett V.
    Kubiak, Peter
    Okpara, Chinyere
    Smith, Alan D.
    Motzer, Robert J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] A phase 1b trial of lenvatinib (LEN) plus pembrolizumab (PEM) in patients with selected solid tumors
    Taylor, M.
    Dutcus, C. E.
    Schmidt, E.
    Bagulho, T.
    Li, D.
    Shumaker, R.
    Rasco, D.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [10] Lenvatinib plus Pembrolizumab for Renal Cell Carcinoma
    Hindie, Elif
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (03): : 287 - 287
12345